AGIOS PHARMACEUTICALS, INC. — Operating Income by Fiscal Year

15 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/01052148-8d63-4819-b966-b8a3c9f51808/serie/operating-income

Fiscal yearOperating IncomePeriodEvidence
FY 2025$-472.1M2025-01-01 – 2025-12-31evidence 0001439222-26-000025
FY 2024$-425.7M2024-01-01 – 2024-12-31evidence 0001439222-25-000009
FY 2023$-391.5M2023-01-01 – 2023-12-31evidence 0001439222-24-000035
FY 2022$-389.0M2022-01-01 – 2022-12-31evidence 0001439222-23-000039
FY 2021$-378.4M2021-01-01 – 2021-12-31evidence 0001439222-22-000024
FY 2020$-335.9M2020-01-01 – 2020-12-31evidence 0001439222-22-000024
FY 2019$-316.3M2019-01-01 – 2019-12-31evidence 0001439222-22-000024
FY 2018$-362.5M2018-01-01 – 2018-12-31evidence 0001439222-19-000004
FY 2017$-320.8M2017-01-01 – 2017-12-31evidence 0001439222-18-000004
FY 2016$-201.0M2016-01-01 – 2016-12-31evidence 0001193125-17-046795
FY 2015$-118.7M2015-01-01 – 2015-12-31evidence 0001193125-16-481973
FY 2014$-54.1M2014-01-01 – 2014-12-31evidence 0001193125-15-060046
FY 2013$-38.9M2013-01-01 – 2013-12-31evidence 0001193125-14-104521
FY 2012$-23.0M2012-01-01 – 2012-12-31evidence 0001193125-14-104521
FY 2011$-16.6M2011-01-01 – 2011-12-31evidence 0001193125-14-104521
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

AGIOS PHARMACEUTICALS, INC. — all facts · Revenue · Net Income